01 March 2006
Lipoprotein(a) and lipid profile in patients with atrial fibrillation.
José Antonio Díaz-Peromingo, Ana Albán-Salgado, Florinda García-Suárez, Joaquín Sánchez-Leira, Juan Saborido-Froján, Marina Iglesias-GallegoMed Sci Monit 2006; 12(3): CR122-125 :: ID: 447110
Abstract
Background: Atrial fibrillation (AF) is well-known risk factor for cardiacembolic events, especially cerebrovascular events. The association between AF and lipid markers was evaluated.Among all these markers, lipoprotein(a), or (Lp(a), was also investigated. The aim of our study was toevaluate the characteristics of the lipid profile in patients with AF, focusing on Lp(a) levels. Material/Methods:One hundred and one patients with AF were included in the study group. We used 101 patients without AF,matched by sex and age with the study group, as the control group. Total cholesterol, low-density lipoproteincholesterol, high-density lipoprotein cholesterol, triglycerides, Lp(a), and the LDL/HDL, COL/LDL, andCOL/HDL indexes were measured. The study was performed in Spain with a Caucasian population. Results:Among all the variables included there was statistical difference only between groups in the COL/HDLindex, showing a greater value in the group of patients with AF. No difference was found in Lp(a) levelsbetween the groups. Conclusions: Although some studies have tried to show a possible relationship betweenAF and high Lp(a) levels, we found no such relationship in our study, although ethnic differences couldexplain, at least in part, these results in our patients when compared with other ethnic populations.
Keywords: European Continental Ancestry Group - genetics, Triglycerides - genetics, Risk Factors, Lipoproteins, LDL - genetics, Lipoprotein(a) - genetics, Lipids - genetics, Atrial Fibrillation, Enzyme-Linked Immunosorbent Assay, Cholesterol, LDL - genetics, Cholesterol, HDL - genetics, Cholesterol - genetics, Case-Control Studies, Biological Markers - blood
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952